Ampersand Capital Partners Adds Operating Partner

WELLESLEY, Mass., June 12, 2013 /PRNewswire/ -- Ampersand Capital Partners, a healthcare-focused, middle market private equity firm, is pleased to announce the addition of Cecil Kost as an Operating Partner.  Cecil will work with the Ampersand investment team to identify and evaluate new platform opportunities as well as assist on the existing portfolio.

Cecil has more than 30 years of healthcare operating experience in Ampersand's target investment segments including laboratory/diagnostics products, pharmaceutical services and medical products.  Most recently he served as President and CEO of Precision Dynamics Corp., the global leading manufacturer of patient identification solutions.  Prior experience includes serving as CEO of MedManage Systems, Inc. and President/COO of Oncor, Inc.  Cecil began his career at Curtin Matheson Scientific, where he spent nearly 20 years serving in senior management roles building the company into a industry leading distributor of lab products and clinical diagnostics prior to its acquisition by Fisher Scientific.

Cecil serves as a Board member of InDemand Interpreting and Infonaut, Inc., and is a former Chairman of the Laboratory Products Association.  He holds a B.S. from Tulane University.

"I am thrilled to join the Ampersand team," said Cecil Kost.  "I believe that Ampersand is well positioned to partner with growth-oriented middle market companies, and I am looking forward to working with the Ampersand team to create meaningful value in their portfolio companies." 

"We are excited to have Cecil join Ampersand," said Herbert Hooper, Managing Partner at Ampersand.  "Cecil's experience in our core investment segments is highly complementary to our team.  I am confident that Cecil will be able to leverage his years of operational experience to identify quality healthcare businesses that can benefit from Ampersand's unique expertise, and then help them achieve their goals."

About Ampersand
Ampersand is a Boston-based private equity firm with a focus on middle market growth equity investments in the Healthcare sector.  Ampersand leverages its unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams.  Over the past twenty years, Ampersand has raised seven funds, producing a 24% pooled internal rate of return to Limited Partners (net of all fees and carried interest).  To learn more about Ampersand, visit www.ampersandcapital.com.

SOURCE Ampersand Capital Partners